Videos
Treating Influenza with Aculife Electronic Acupuncture
 | Discover an alternative to paracetemol and vitamin c for alleviating the symptoms of influenza. Electro-acupuncture can help deal with the uncomfortable symptoms of influenza and speed up your recovery time. "www.GetAculifeNow.com" | Views: 8  0 ratings |
| Time: 03:14 | More in People & Blogs |
HubMed - Acupuncture
Acupuncture transcutaneous electrical nerve stimulation reduces discomfort associated with barostat-induced rectal distension: A randomized-controlled study.
World J Gastroenterol. 2013 Jan 21; 19(3): 381-388
Leung WW, Jones AY, Ng SS, Wong CY, Lee JF
AIM: To explore the effectiveness of acupuncture transcutaneous electrical nerve stimulation (Acu-TENS), a non-invasive modality in reduction of rectal discomfort during barostat-induced rectal distension.METHODS: Forty healthy subjects were randomized to receive 45 min of either Acu-TENS or placebo-TENS (no electrical output) over acupuncture points Hegu (large-intestine 4), Neiguan (pericardium 6) and Zusanli (stomach 36). A balloon catheter attached to a dual-drive barostat machine was then inserted into the subjects' rectum. A step-wise (4 mmHg) increase in balloon pressure was induced until maximal tolerable or 48 mmHg. Visual analogue scale and a 5-point subjective discomfort scale (no perception, first perception of distension, urge to defecate, discomfort/pain and extreme pain) were used to assess rectal discomfort at each distension pressure. Blood beta-endorphin levels were measured before, immediately after intervention, at 24 mmHg and at maximal tolerable distension pressure.RESULTS: There was no difference in the demographic data and baseline plasma beta-endorphin levels between the two groups. Perception threshold levels were higher in the Acu-TENS group when compared to the placebo group, but the difference reached statistical significance only at the sensations "urge to defecate" and "pain". The distension pressures recorded at the "urge to defecate" sensation for the Acu-TENS and placebo-TENS groups were 28.0 ± 4.5 mmHg and 24.6 ± 5.7 mmHg, respectively (P = 0.043); and the pressures recorded for the "pain" sensation for these two groups were 36.0 ± 4.2 mmHg and 30.5 ± 4.3 mmHg respectively (P = 0.002). Compared to the placebo group, a higher number of participants in the Acu-TENS group tolerated higher distension pressures (> 40 mmHg) (65% in Acu-TENS vs 25% in placebo, P = 0.02). The plasma beta-endorphin levels of the Acu-TENS group were significantly higher than that of the placebo group at barostat inflation pressure of 24 mmHg (1.31 ± 0.40 ng/mL vs 1.04 ± 0.43 ng/mL, P = 0.044) and at maximal inflation pressure (1.46 ± 0.53 ng/mL vs 0.95 ± 0.38 ng/mL, P = 0.003).CONCLUSION: Acu-TENS reduced rectal discomfort during barostat-induced rectal distension and concurrently associated with a rise in beta-endorphin level.
HubMed - Low Level Laser therapy
Laser Therapy in Metabolic Syndrome-related Kidney Injury.
Photochem Photobiol. 2013 Jan 29;
Ucero AC, Sabban B, Benito-Martin A, Carrasco S, Joeken S, Ortiz A
Metabolic syndrome is characterized by hyperglycemia, hypertension, dyslipidemia, and obesity. Diabetes and hypertension are the main causes of chronic end-stage kidney disease in humans. Chronic kidney disease is characterized by kidney inflammation and eventual development of kidney fibrosis. Low-level laser (or light) therapy (LLLT) can be used to relieve pain associated with some inflammatory diseases due to photochemical effects. Despite the known contribution of inflammation to metabolic syndrome and kidney disease, there is scarce information on the potential therapeutic use of LLLT in renal disease. The aim of this randomized, placebo-controlled study was to test the hypothesis that LLLT could modulate chronic kidney injury. Rats with nephropathy, hypertension, hyperlipidemia, and type II diabetes (strain ZSF1) were subjected to three different conditions of LLLT or sham treatment for eight weeks, and then sacrificed ten weeks later. The main findings of this study are that the LLLT-treated rats had lower blood pressure after treatment and a better preserved glomerular filtration rate with less interstitial fibrosis upon euthanasia at the end of follow-up. This initial proof-of-concept study suggests that LLLT may modulate chronic kidney disease progression, providing a painless, non-invasive, therapeutic strategy, which should be further evaluated. © 2013 Wiley Periodicals, Inc. Photochemistry and Photobiology © 2013 The American Society of Photobiology.
Videos
On Alcohol and Tobacco
 | Self Help Coach, Holistic Practitioner and Shaman Isantis Tao speaks out on Alcohol and Tobacco's controversial blame for modern health problems, and reveals the TRUTH about Alcohol and Tobacco's effects on your health. www.truelifedevelopment.com | Views: 0 0 ratings |
| Time: 07:07 | More in Education |
No comments:
Post a Comment